Why the study?
The study evaluated the impact of baseline eGFR on clinical and angiographic outcomes and long-term in-stent restenosis rates in patients undergoing elective CAS.
Does lower baseline eGFR predict increased 3-year in-stent restenosis rates in patients undergoing elective carotid artery stenting?
Does lower baseline eGFR predict increased 3-year in-stent restenosis rates in patients undergoing elective carotid artery stenting?
Lower baseline eGFR is a significant predictor of increased 3-year in-stent restenosis after elective carotid artery stenting with first-generation stents.
This study evaluated the impact of the baseline estimated glomerular filtration rate (eGFR) on clinical and angiographic outcomes and long-term in-stent restenosis (ISR) rates in patients undergoing elective carotid artery stenting (CAS) procedures. Consecutive patients who underwent CAS were retrospectively enrolled (n = 456). At the end of 3 years of follow-up, patients who had died or were lost follow-up were excluded from the study and a final analysis was performed using data from the remaining 405 patients. The study population (n = 405) was divided into 3 tertiles based on the tertile values of the eGFR level (T1, T2, and T3); then, clinical and procedural characteristics and 3-year ISR rates were compared between the groups. An ISR of 50% was detected in 49 (12%) surviving patients. The 3-year ISR was higher among patients with the lowest eGFR values (T1) by 3.7 times (95% CI: 2.01-11.38) than that among patients with the highest eGFR values (T3). These significant relationships persisted following adjustment for confounders. A lower baseline eGFR level was significantly associated with an increased ISR rate. Decreased renal function may be a predictor of ISR after CAS using first-generation stents.
No takes yet. Share an insight, caveat, or question.
Ösken et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: